Mutation
The putative cancer-causing PDGs driven by somatic mutations were predicted by integration of five complementary methods to identify the genes with mutations that have significant signs of positive selection during tumor evolution.
| Showing page 130 |
first page | previous page | next page | last page |
| HGNC Symbol | Ensembl Gene ID | Overall_Mscore | No. of Cancer Types |
| IGHM | ENSG00000211899 | 0.00 | 0 |
| SHH | ENSG00000164690 | 0.00 | 0 |
| ENHO | ENSG00000168913 | 0.00 | 0 |
| KCND1 | ENSG00000102057 | 0.00 | 0 |
| PAPPA2 | ENSG00000116183 | 0.00 | 0 |
| IL19 | ENSG00000142224 | 0.00 | 0 |
| MARK1 | ENSG00000116141 | 0.00 | 0 |
| AGT | ENSG00000135744 | 0.00 | 0 |
| PRKCQ | ENSG00000065675 | 0.00 | 0 |
| COMTD1 | ENSG00000165644 | 0.00 | 0 |
| MMP17 | ENSG00000198598 | 0.00 | 0 |
| GALC | ENSG00000054983 | 0.00 | 0 |
| SERPINA10 | ENSG00000140093 | 0.00 | 0 |
| AKT1 | ENSG00000142208 | 0.32 | 5 |
| EPB42 | ENSG00000166947 | 0.00 | 0 |
| CNTNAP3B | ENSG00000154529 | 0.00 | 0 |
| IGFALS | ENSG00000099769 | 0.00 | 0 |
| TXNDC11 | ENSG00000153066 | 0.00 | 0 |
| PLA2G10 | ENSG00000069764 | 0.00 | 0 |
| CYLD | ENSG00000083799 | 0.03 | 1 |
|
Showing page 130 |
first page | previous page | next page | last page |